Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans
Date
2009-02-17ICR Author
Author
Alonzi, R
Padhani, AR
Maxwell, RJ
Taylor, NJ
Stirling, JJ
Wilson, JI
d Arcy, JA
Collins, DJ
Saunders, MI
Hoskin, PJ
Type
Journal Article
Metadata
Show full item recordAbstract
Hypoxia has been associated with poor local tumour control and relapse in many cancer sites, including carcinoma of the prostate. This translational study tests whether breathing carbogen gas improves the oxygenation of human prostate carcinoma xenografts in mice and in human patients with prostate cancer. A total of 23 DU145 tumour-bearing mice, 17 PC3 tumour-bearing mice and 17 human patients with prostate cancer were investigated. Intrinsic susceptibility-weighted MRI was performed before and during a period of carbogen gas breathing. Quantitative R(2)* pixel maps were produced for each tumour and at each time point and changes in R(2)* induced by carbogen were determined. There was a mean reduction in R(2)* of 6.4% (P = 0.003) for DU145 xenografts and 5.8% (P = 0.007) for PC3 xenografts. In all, 14 human subjects were evaluable; 64% had reductions in tumour R(2)* during carbogen inhalation with a mean reduction of 21.6% (P = 0.0005). Decreases in prostate tumour R(2)* in both animal models and human patients as a result of carbogen inhalation suggests the presence of significant hypoxia. The finding that carbogen gas breathing improves prostate tumour oxygenation provides a rationale for testing the radiosensitising effects of combining carbogen gas breathing with radiotherapy in prostate cancer patients.
Collections
Research team
Magnetic Resonance
Language
eng
License start date
2009-02-17
Citation
BRITISH JOURNAL OF CANCER, 2009, 100 pp. 644 - 648
Publisher
NATURE PUBLISHING GROUP